From September 16 to 18, Winner Medical Group (Stock Code: 300888) hosted its fifth listing anniversary celebration in Wuhan. Ms. Huang Ling, Secretary-General of Hubei Listed Companies Association, and Ms. Jiang Wei, Deputy Secretary-General of Shenzhen Listed Companies Association, attended the event alongside Winner Medical Group representatives, investors, and media delegates to commemorate this significant milestone.
The event centered on the theme "Brand Upgrading and Steady Growth," serving both as a reflection on Winner Medical Group's remarkable achievements over the past five years and as a vision for future development and strategic planning.
**Staying True to Original Vision Through Five Years of Progress**
During the celebration, Mr. Li Jianquan, Chairman of Winner Medical and founder of Purcotton, reflected on his entrepreneurial journey. From the company's establishment in 1991, through the 2001 determination to eliminate China's "Rubbish" production reputation and establish Winner Medical as the industry's leading exporter, to the 2009 launch of Purcotton marking the transition from strict medical focus to dual medical and consumer goods operations, Winner Medical Group has taken each step with determination and strength.
Mr. Li Jianquan remarked: "Every step of Winner Medical Group's growth has been inseparable from China's economic development backdrop, the support of partners and investors, and most importantly, consumer trust. We consistently uphold long-termism and altruism principles, maintaining our original intention to 'build Chinese brands' while dedicating ourselves to creating value for shareholders and society."
Winner Medical Group has achieved remarkable results over its five listed years. Mr. Fang Xiuyuan, Director and Chief Financial Officer of Winner Medical, noted that the company maintained approximately 15% compound annual revenue growth over the past five years, reaching 9 billion yuan in revenue for 2024, demonstrating resilient growth trajectory amid market fluctuations.
With over thirty years of industry expertise, Winner Medical Group has successfully navigated multiple economic and industry development cycles. In 2024, the medical segment maintained resilient growth supported by "internal acceleration and external integration," while the consumer goods segment continued its upward momentum, with core breakthrough products like dry and wet cotton soft towels and sanitary napkins driving growth and delivering solid overall segment performance.
Winner Medical Group has consistently adhered to an "investor-oriented" philosophy, actively returning value to capital markets through cash dividends and share buybacks. The company has maintained annual cash dividends since listing, with dividend ratios increasing yearly. As of mid-2025, cumulative cash dividends reached 2.88 billion yuan, with share buyback cash payments totaling 690 million yuan, combining for 100.3% of net IPO proceeds. Currently, all fundraised capital has been deployed according to plan, with all six major investment projects achieving operational status, providing solid support for the company's dual-engine strategy implementation.
These achievements represent the collective efforts of all Winner Medical Group members and best exemplify the original vision of "taking Chinese manufacturing to the world."
**ESG Strategy Launch: Blueprint for Sustainable Development**
During the fifth anniversary celebration, Ms. Chen Huixuan, Vice General Manager and Board Secretary of Winner Medical, officially unveiled Winner Medical Group's ESG strategy.
Winner Medical Group places high importance on environmental, social, and governance work, comprehensively integrating sustainable development concepts into strategy and operations. The company has published ESG reports for five consecutive years since its listing debut, achieving an A-level Wind ESG rating in 2025. In governance, the company has progressively established comprehensive management systems providing strong support for steady development; environmentally, it actively addresses climate change, sets carbon peak and neutrality targets, develops green products, and collaborates with supply chain partners to promote cotton industry green upgrading; socially, it focuses on building responsible supply chains, actively participates in social welfare initiatives, achieving symbiotic prosperity between corporate and social value.
Ms. Chen Huixuan emphasized: "The ESG strategy launch represents Winner Medical Group's commitment to social responsibility and planning for future sustainable development."
During interactive sessions, investors and media representatives showed keen interest in future planning and profit potential for both business segments, breakthrough product strategies for cotton soft towels and sanitary napkins, overseas market opportunities, and channel strategies. Active questioning led to in-depth exchanges with Winner Medical Group's senior management. These interactions enhanced understanding of Winner Medical Group while bringing new perspectives and inspiration for future company development.
**Factory Visits: Witnessing Quality Commitment**
During the event, investors and media representatives toured Winner Medical Group's Wuhan and Huanggang facilities with staff members. Guests visited key areas including the cotton spunlace nonwoven production lines, sterilization centers, and intelligent automated warehouses, witnessing firsthand Winner Medical Group's stringent product quality control and high attention to production safety.
Ms. Liao Meizhen, Director of Winner Medical and Senior Vice President of Purcotton, stated that Purcotton consistently adheres to a development strategy of "product leadership, operational excellence, brand upgrading, and global vision," providing consumers with high-quality cotton products through continuous technological innovation and product upgrades. Over the next three years, Purcotton will strengthen "all-cotton, full-category" brand awareness by building absolute advantages in strategic products with more breakthrough products and scenario penetration.
Simultaneously, Winner Medical Group's medical segment continues upgrading and iteration. Ms. Zhang Yan, Director of Winner Medical and Marketing Vice President of the Medical Segment, indicated that the medical segment has achieved self-iteration and sustained growth through over thirty years of industry accumulation. Looking ahead, Winner Medical will focus on high-growth areas including premium wound management, green operating rooms, and medical-grade health personal care, meeting market demand for high-quality medical products through technological innovation and product upgrades, while accelerating global channel deployment to enhance international market competitiveness and contribute to global healthcare initiatives.
**Future Outlook: Continuing the Brilliant Chapter**
Standing at the fresh starting point of the fifth listing anniversary, Winner Medical Group will continue innovating and embracing globalization. On one hand, the company will persistently drive technological iteration through R&D, bringing Winner Medical Group products to more countries and regions; on the other hand, the company will use "green symbiotic chains" as connections to promote sustainable development in the global health sector.
Winner Medical Group's "brand upgrading" represents not only corporate growth but also an epitome of Chinese brands going global. Mr. Li Jianquan, Chairman of Winner Medical and founder of Purcotton, stated: "Over the next five years and even the next thirty-five years, generations of Winner Medical people will operate within the national strategic framework, based in China while facing the world, building the company into a global synonym for high quality among peers and a trusted brand in consumers' hearts."
Comments